Latest News in the pharma Industry

Top Stories

Roche and BMS Ink Skin Cancer Pact

Roche and BMS Ink Skin Cancer Pact

3 Jun 2011

Under the agreement, the two companies will conduct a Phase I/II study to evaluate the safety and efficacy of the combination.

Read more 
Pfizer & Hisun to Establish JV for Branded Generics

Pfizer & Hisun to Establish JV for Branded Generics

3 Jun 2011

The two companies aim to strengthen the ability to reach more patients with high-quality and low-cost medicines in the branded generics arena.

Read more 
Evotec Acquires Compound Focus for €12.5M

Evotec Acquires Compound Focus for €12.5M

2 Jun 2011

Evotec said the transaction would substantially augment its early drug discovery, provide critical mass to its existing compound management offering, and add profitable revenues.

Read more 
Merck Establishes Expert Advisory Panel for Bioethical Issues

Merck Establishes Expert Advisory Panel for Bioethical Issues

1 Jun 2011

The Merck Bioethics Advisory Panel will provide the company with recommendations on how to take bioethical aspects into account when discovering and developing new products and processes.

Read more 
Ashland to Acquire ISP for $3.2B

Ashland to Acquire ISP for $3.2B

1 Jun 2011

Specialty chemical company Ashland plans to acquire chemical manufacturer International Specialty Products in a $3.2 billion all-cash deal.

Read more 
Bayer Moves Betaseron Manufacturing Facility to Germany

Bayer Moves Betaseron Manufacturing Facility to Germany

1 Jun 2011

Bayer HealthCare will relocate its production of blockbuster multiple sclerosis drug Betaseron to Germany for greater flexibility in the marketplace.

Read more 
J&J Seeks Approval for 11 New Drugs

J&J Seeks Approval for 11 New Drugs

30 May 2011

Johnson & Johnson plans to seek approval for 11 new drugs by 2015 as it revives its pharmaceuticals business.

Read more 
Emergent Expects Government Order for Anthrax Vaccine

Emergent Expects Government Order for Anthrax Vaccine

30 May 2011

Emergent has delivered more than 42 million doses of BioThrax to the US Government, and more than ten million doses have been administered to military personnel.

Read more 
Pharmascience Acquires Aegera to Facilitate R&D

Pharmascience Acquires Aegera to Facilitate R&D

30 May 2011

Pharmascience, the largest generic pharmaceutical company in Quebec, announced last Friday the acquisition of Aegera Therapeutics Inc., a Montreal-based clinical-stage biotechnology company.

Read more 
India & Italy to Strengthen Ties in Pharma Sector

India & Italy to Strengthen Ties in Pharma Sector

30 May 2011

The growth rate of pharma exports from India to Italy in the recent past has been below 10 per cent and the joint working group. The working group will boost the exports through closer cooperation.

Read more 
EMA Recommends Revaccination for Travellers in Need of Protection with Ixiaro

EMA Recommends Revaccination for Travellers in Need of Protection with Ixiaro

30 May 2011

Intercell AG is recalling batch JEV09L37 of vaccine Ixiaro throughout the EU. The CHMP recommends that revaccination with a different batch should be considered.

Read more 
Pfizer Signs Partnership Deal with ICON and PAREXEL

Pfizer Signs Partnership Deal with ICON and PAREXEL

27 May 2011

Pfizer has selected Boston-based Parexel, and Dublin, Ireland-based Icon, as its two preferred CROs for the provision of clinical development and trials services.

Read more